Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
多渠道沟通以改善服务不足人群的癌症教育和结果 (MICEO)
基本信息
- 批准号:10892444
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:17 year oldAddressAdministrative SupplementAdultAwardCancer CenterCancer EtiologyCaregiversCaringCatchment AreaClinicCommunicationCommunitiesCommunity OutreachComprehensive Cancer CenterComputerized Medical RecordDataDisparityEducationEducation and OutreachEnsureFamilyGeneral PopulationGoalsHuman Papilloma Virus VaccinationHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusIntentionKnowledgeMeasuresMonitorOutcomeParentsPatient EducationPatientsPositioning AttributePrevention programPrintingSaint Jude Children&aposs Research HospitalSecond Primary CancersSurvivorsSystemTestingUnderserved PopulationVaccinatedVaccinationage groupcancer educationchildhood cancer survivorcollaborative approachcommunity engagementdesigneducation resourcesexperiencehealth literacyhuman old age (65+)improvedinnovationmobile applicationoncology programonline resourcepeerpilot testprocess evaluationsocial media
项目摘要
PROJECT ABSTRACT
Childhood cancer survivors are a high-priority, underserved population for HPV vaccination. They are less
likely to be vaccinated when compared to the general population and are more likely to develop second
cancers caused by HPV as adults. St. Jude Comprehensive Cancer Center (SJCCC) is uniquely positioned to
address observed disparities in HPV vaccination coverage among childhood cancer survivors by leveraging
our unique reach across our catchment area and building on award-winning, state-of-the-art communication
systems with those treated at SJCCC and their families. The overall goal of the proposed administrative
supplement is to improve HPV vaccination coverage among childhood cancer survivors. The specific aims are
to: (1) develop an innovative, culturally targeted, multi-channel educational campaign to enhance health
literacy related to HPV vaccination and to improve HPV vaccination coverage among childhood cancer
survivors; and (2) pilot test the multi-channel educational campaign to understand its impact on knowledge and
intention and to inform the next steps. Our proposed plan will build on established and newly developed patient
families and survivor-facing educational resources in English and Spanish, which are designed and
disseminated to promote and facilitate health literacy. Our approach will be highly iterative and include
engagement of key offices within St. Jude, including SJCCC Community Outreach and Engagement, HPV
Cancer Prevention Program, Strategic Communication, Education and Outreach, Patient Family Centered
Care, Patient Experience Office, Transition Oncology Program, After Completion of Therapy Clinic, and most
importantly, through our regular interaction with patient families and childhood cancer survivors through the
Patient Family Advisory Council and additional patient family advisors. The multi-channel campaign will focus
on web-based resources and communities, social media platforms, Our St. Jude mobile application (app),
traditional print formats, electronic medical record prompts for prescribed patient education, and peer-to-peer,
patient family champion experiences. We will target the 10-30-year-old age group with approaches
differentiated by 10-17-year-olds for whom parent/caregivers make vaccination decisions and 18-30-year olds
who can make vaccination decisions for themselves, in most instances. We will develop and pilot test an HPV
vaccination campaign across these multiple channels. Our project activities will be documented and monitored
through a comprehensive process evaluation. The preliminary impact of our efforts will also be measured using
qualitative, quantitative, and analytical data, including assessment of aggregated HPV vaccination rates before
and after the campaign implementation period. Our efforts will be aligned with St. Jude communication and
educational resources from the beginning to optimize sustainability. We will openly share our findings with
other cancer centers and organizations serving childhood cancer survivors and continue to refine and test our
approaches to ensure we are achieving impact through increased HPV vaccination coverage among childhood
cancer survivors.
项目摘要
儿童癌症幸存者是 HPV 疫苗接种的高度优先且服务不足的人群。他们比较少
与一般人群相比,他们更有可能接种疫苗,并且更有可能出现第二次感染
成人时由 HPV 引起的癌症。圣裘德综合癌症中心 (SJCCC) 具有独特的优势
通过利用以下方法解决儿童癌症幸存者中观察到的 HPV 疫苗接种覆盖率差异
我们在整个服务区域拥有独特的影响力,并以屡获殊荣的最先进的沟通为基础
系统与在 SJCCC 接受治疗的患者及其家人建立联系。拟议行政管理的总体目标
补充品旨在提高儿童癌症幸存者的 HPV 疫苗接种覆盖率。具体目标是
(1) 开展创新的、有针对性的、多渠道的教育活动,以增强健康
提高 HPV 疫苗接种相关知识并提高儿童癌症中 HPV 疫苗接种覆盖率
幸存者; (2) 试点多渠道教育活动,了解其对知识和知识的影响
意向并告知后续步骤。我们提出的计划将建立在现有和新开发的患者基础上
面向家庭和幸存者的英语和西班牙语教育资源,这些资源的设计和
传播以促进和促进健康素养。我们的方法将是高度迭代的,包括
St. Jude 内主要办公室的参与,包括 SJCCC 社区外展和参与、HPV
癌症预防计划、战略沟通、教育和外展、以患者家庭为中心
护理、患者体验办公室、过渡肿瘤学计划、治疗诊所完成后以及大多数
重要的是,通过我们与患者家属和儿童癌症幸存者的定期互动
患者家庭咨询委员会和其他患者家庭顾问。多渠道活动将重点关注
基于网络的资源和社区、社交媒体平台、我们的 St. Jude 移动应用程序 (app)、
传统的打印格式、电子病历提示规定的患者教育以及点对点,
患者家庭冠军经历。我们将针对10-30岁年龄段采取措施
区分为由父母/看护者做出疫苗接种决定的 10-17 岁儿童和 18-30 岁儿童
在大多数情况下,谁可以自己做出疫苗接种决定。我们将开发并试点测试 HPV
通过这些多种渠道开展疫苗接种活动。我们的项目活动将被记录和监控
通过全面的过程评估。我们的努力的初步影响也将通过以下方式来衡量:
定性、定量和分析数据,包括之前对 HPV 疫苗接种率的评估
以及活动实施期结束后。我们的努力将与圣裘德的沟通和
教育资源从一开始就持续优化。我们将公开分享我们的发现
其他癌症中心和组织为儿童癌症幸存者提供服务,并继续完善和测试我们的
确保我们通过提高儿童 HPV 疫苗接种覆盖率取得影响的方法
癌症幸存者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES ROBERTS其他文献
CHARLES ROBERTS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES ROBERTS', 18)}}的其他基金
Cancer-based discovery of novel mechanisms of chromatin control
基于癌症的染色质控制新机制的发现
- 批准号:
10660680 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Development and Piloting of a Stigma Assessment Tool for Global Pediatric Cancer
全球儿童癌症耻辱评估工具的开发和试点
- 批准号:
10844719 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Enhancing Precision of Pediatric Cancer Molecular Targets by Aggregating CCDI Genomic Data to Pediatric Cancer Knowledgebase
将CCDI基因组数据汇总到小儿癌症知识库,提高小儿癌症分子靶点的精准度
- 批准号:
10877602 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Role of the SWI/SNF complex in tumor suppression
SWI/SNF 复合物在肿瘤抑制中的作用
- 批准号:
10463748 - 财政年份:2013
- 资助金额:
$ 20万 - 项目类别:
Role of the SWI/SNF complex in tumor suppression
SWI/SNF 复合物在肿瘤抑制中的作用
- 批准号:
10248410 - 财政年份:2013
- 资助金额:
$ 20万 - 项目类别:
Analysis of the role of the SWI/SNF complex in tumor suppression
SWI/SNF复合物抑制肿瘤的作用分析
- 批准号:
8689980 - 财政年份:2013
- 资助金额:
$ 20万 - 项目类别:
Analysis of the role of the SWI/SNF complex in tumor suppression
SWI/SNF复合物抑制肿瘤的作用分析
- 批准号:
8579030 - 财政年份:2013
- 资助金额:
$ 20万 - 项目类别:
The function of Snf5, an epigenetic tumor suppressor
表观遗传肿瘤抑制因子 Snf5 的功能
- 批准号:
7086815 - 财政年份:2005
- 资助金额:
$ 20万 - 项目类别:
The function of Snf5, an epigenetic tumor suppressor
表观遗传肿瘤抑制因子 Snf5 的功能
- 批准号:
8676680 - 财政年份:2005
- 资助金额:
$ 20万 - 项目类别:
The function of Snf5, an epigenetic tumor suppressor
表观遗传肿瘤抑制因子 Snf5 的功能
- 批准号:
6906661 - 财政年份:2005
- 资助金额:
$ 20万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Research Grant














{{item.name}}会员




